Literature DB >> 9533872

On the origin of plasmid-borne, extended-spectrum, antibiotic resistance mutations in bacteria.

F Bastarrachea1.   

Abstract

Many antibiotic resistance mutations arise in pathogenic bacteria that harbor plasmids (R-plasmids). Resistance to third generation cephalosporins, for instance, largely occurs by one or more point mutations in plasmid bla genes that expand the resistance spectrum of beta-lactamases. Here I review relevant evidence underlying the worldwide emergence of extended spectrum beta-lactamases (ESBLs). The conclusion reached is that the origin of these resistance-conferring mutations cannot be explained by a series of single point mutation and selection events. Instead, highly advantageous stochastic processes might exist that generate alterations in the sequence or the conformation of particular regions in chromosomal or plasmid genomes such as bla, i.e., recombination or mutation. Several explanations for the origin of ESBLs are reviewed but direct experimental evidence to support or to invalidate them is still lacking. The cellular conditions under which ESBLs arise are unknown; however, involvement of nutritional stresses inside natural animal hosts and of plasmid conjugal functions appear likely. Copyright 1998 Academic Press Limited.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9533872     DOI: 10.1006/jtbi.1997.0563

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  2 in total

1.  Increased mutation frequencies in Escherichia coli isolates harboring extended-spectrum beta-lactamases.

Authors:  María-Rosario Baquero; Juan Carlos Galán; María del Carmen Turrientes; Rafael Cantón; Teresa M Coque; José Luis Martínez; Fernando Baquero
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

2.  Antibiotic-resistant soil bacteria in transgenic plant fields.

Authors:  Sandrine Demanèche; Hervé Sanguin; John Poté; Elisabeth Navarro; Dominique Bernillon; Patrick Mavingui; Walter Wildi; Timothy M Vogel; Pascal Simonet
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.